Top Banner
Neuromonitoring in anesthesia
62

Neuromonitoring in anesthesia

Jul 15, 2015

Download

Health & Medicine

dranest87
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Neuromonitoring in anesthesia

Neuromonitoring in anesthesia

Page 2: Neuromonitoring in anesthesia

Classification of monitoring techniques:

The brain can be monitored in terms of:

Function

Cerebral blood flow (CBF) & intracranial pressure (ICP)

Brain oxygenation and metabolism

Page 3: Neuromonitoring in anesthesia

Monitoring of FUNCTION:

Electroencephalograms (EEG) Raw EEG

Computerized Processed EEG: Compressed spectral array, Density spectral array, Aperiodic analysis, Bispectral analysis (BIS)

Evoked Potential Sensory EP:

Somatosensory EP

Visual EP

Brain stem auditory EP

Motor EP:

- Transcranial magnetic MEP

- Transcranial electric MEP

- Direct spinal cord stimulation

EMG

- Cranial nerve function (V, VII, IX, X, XI, XII)

Page 4: Neuromonitoring in anesthesia

EEG

Page 5: Neuromonitoring in anesthesia

EEG

Electroencephalogram – surface recordings of the summation of excitatory and inhibitory postsynaptic potentials generated by pyramidal cells in cerebral cortex

EEG:

Measures electrical function of brain

Indirectly measures blood flow

Measures anesthetic effects

Page 6: Neuromonitoring in anesthesia

EEG

Three uses perioperatively:

Identify inadequate blood flow to cerebral cortex caused by surgical/anesthetic-induced reduction in flow

Guide reduction of cerebral metabolism prior to induced reduction of blood flow

Predict neurologic outcome after brain insult

Other uses: identify consciousness, unconsciousness, seizure activity, stages of sleep, coma

Page 7: Neuromonitoring in anesthesia

EEG

Electrodes placed so that mapping system relates surface head anatomy to underlying brain cortical regions

3 parameters of the signal: Amplitude – size or

voltage of signal Frequency – number of

times signal oscillates Time – duration of the

sampling of the signal

Page 8: Neuromonitoring in anesthesia

EEG

EEG Waves :

Beta: high freq, low amp (awake state)

Alpha: med freq, high amp (eyes closed while awake)

Theta: Low freq (not predominant)

Delta: very low freq high amp (depressed functions/deep coma

Page 9: Neuromonitoring in anesthesia

Abnormal EEG

Regional problems - asymmetry in frequency, amplitude or unpredicted patterns of such Epilepsy – high voltage spike with slow waves

Ischemia – slowing frequency with preservation of amplitude or loss of amplitude (severe)

Global problems – affects entire brain, symmetric abnormalities Anesthetic agents induce global changes similar to global

ischemia or hypoxemia (control of anesthetic technique is important

Page 10: Neuromonitoring in anesthesia

Anesthetic agents and EEG

Subanesthetic doses of inhaled anesthetics (0.3 MAC): Increases frontal beta activity (low voltage, high frequency)

Light anesthesia (0.5 MAC): Larger voltage, slower frequency

General anesthesia (1 MAC): Irregular slow activity

Deeper anesthesia (1.25 MAC): Alternating activity

Very deep anesthesia (1.6 MAC): Burst suppression eventually isoelectric

Page 11: Neuromonitoring in anesthesia
Page 12: Neuromonitoring in anesthesia

Non-anesthetic Factors Affecting EEG

Surgical

1. Cardiopulmonary bypass

2. Occlusion of major cerebral vessel (carotid cross-clamping, aneurysm clipping)

3. Retraction on cerebral cortex

4. Surgically induced emboli to brain

Pathophysiologic Factors

1. Hypoxemia

2. Hypotension

3. Hypothermia

4. Hypercarbia and hypocarbia

Page 13: Neuromonitoring in anesthesia

Uses of EEG

1. Carotid endarterectomy

2. Cerebral aneurysm surgery when temporary clipping is used.

3. Cardiopulmonary bypass procedure

4. Extracranial-intracranial bypass procedure

5. Deliberate metabolic supression for cerebral protection.

Surgery that place the brain at risk (difficulties: restricted access)

Seizure monitoring in ICU

Page 14: Neuromonitoring in anesthesia

Processed EEG

The gold standard for intra-op EEG monitoring: continuous visual inspection of a 16- to 32-channel analog EEG by experienced electroencephalographer

“Processed EEG”: methods of converting raw EEG to a plot showing voltage, frequency, and time Monitors fewer channels, less experience required Reasonable results obtained.

The common processing techniques used are time domain analysis and frequency domain analysis.

Page 15: Neuromonitoring in anesthesia

Time domain analysis

EEG is split into small epochs of a given duration, usually about 1-4 sec.

The frequency and/or amplitude information contained in each epoch is depicted graphically.

A change in the value of the variables derived form this display is expected to represent a change in the raw EEG.

Page 16: Neuromonitoring in anesthesia

Frequency domain analysis

The EEG is split into small epochs.

Each epoch is further resolved into its component sine waves and reconstructed as frequency Vs power plot by using Fourier Analysis.

Compressed Spectral Array (CSA) and Density Modulated Spectral Array (DSA)

Page 17: Neuromonitoring in anesthesia

BIS

Page 18: Neuromonitoring in anesthesia

Entropy

Page 19: Neuromonitoring in anesthesia

EVOKED POTENTIALS

Page 20: Neuromonitoring in anesthesia

Sensory Evoked Potential

Definition: electrical activity generated in response to sensory or motor stimulus

Stimulus given, then neural response is recorded at different points along pathway

Sensory evoked potential Latency – time from stimulus

to onset of SER

Amplitude – voltage of recorded response

Page 21: Neuromonitoring in anesthesia

SEP

Sensory evoked potentials Somatosensory (SSEP) Auditory (BAEP) Visual (VEP)

SSEP – produced by electrically stimulating a cranial or peripheral nerve If peripheral n. stimulated – can record proximally

along entire tract (peripheral n., spinal cord, brainstem, thalamus, cerebral cortex)

As opposed to EEG, records subcortically

Page 22: Neuromonitoring in anesthesia

SSEP

Time-locked, event related, pathway specific EEG in respones of peripheral stimulus

Monitor integrity of the pathway from periphery to the cortex

Electrical stimulator placed at median, ulnar, or posterior tibial nerves

Page 23: Neuromonitoring in anesthesia

Indications for SSEP

Indications: Scoliosis correction Spinal cord decompression and stabilization

after acute injury Brachial plexus exploration Resection of spinal cord tumor Resection of intracranial lesions involving

sensory cortex Clipping of intracranial aneurysms Carotid endarterectomy Thoracic aortic aneurysm repair

Page 24: Neuromonitoring in anesthesia

Carotid endarterectomy

Similar sensitivity has been found between SSEP and EEG

SSEP has advantage of monitoring subcortical ischemia

SSEP disadvantage do not monitor anterior portions -frontal or temporal lobes

Cerebral Aneurysm

SSEP can gauge adequacy of blood flow to anterior cerebral circulation

Evaluate effects of temporary clipping and identify unintended occlusion of perforating vessels supplying internal capsule in the aneurysm clip

Page 25: Neuromonitoring in anesthesia

Limitations

Motor tracts not directly monitored Posterior spinal arteries supply dorsal columns

Anterior spinal arteries supply anterior (motor) tracts

Possible to have significant motor deficit postoperatively despite normal SSEPs

SSEP’s generally correlate well with spinal column surgery

Page 26: Neuromonitoring in anesthesia

• Visual Evoked Potential (VEP)

Using LED goggles to create stimulus

Difficult to perform

• Brainstem Auditory Evoked Potential (BAEP)

Repetitive clicks delivered to the ear

Reflects the VIII nerve & brainstem “well-being”

Page 27: Neuromonitoring in anesthesia

AEP

Page 28: Neuromonitoring in anesthesia

Auditory (BAEP) – rapid clicks elicit responses

CN VIII, cochlear nucleus, rostral brainstem, inferior colliculus, auditory cortex

Procedures near auditory pathway and posterior fossa

Decompression of CN VII, resection of acoustic neuroma, sectioning CNVIII for intractable tinnitus

Resistant to anesthetic drugs

Page 29: Neuromonitoring in anesthesia

Limitations

Responds to injury by increased latency, decreased amplitude, ultimately disappearance

Problem is response non-specific Surgical injury

Hypoperfusion/ischemia

Changes in anesthetic drugs

Temperature changes

Signals easily disrupted by background electrical activity (ECG, EMG activity of muscle movement, etc)

Baseline is essential to subsequent interpretation

Page 30: Neuromonitoring in anesthesia

Anesthetic agents and SEP

Most anesthetic drugs increase latency and decrease amplitude

Exceptions: Nitrous oxide: latency stable, decrease

amplitude Etomidate: increases latency, increase in

amplitude Ketamine: increases amplitude Opiods: no clinically significant changes Muscle relaxants: no changes

Page 31: Neuromonitoring in anesthesia

Physiologic factors affecting SEP’s

Hypotension

Hyperthermia and hypothermia Mild hypothermia (35-36 degrees) minimal effect

Hypoxemia

Hypercapnia

Significant anemia (HCT <15%)

Technical factor: poor electode-to skin-contact and high electrical impedence (egelectrocautery)

Page 32: Neuromonitoring in anesthesia
Page 33: Neuromonitoring in anesthesia

Motor Evoked Potentials

Motor EP:

- Transcranial magnetic MEP

- Transcranial electric MEP

- Direct spinal cord stimulation

Page 34: Neuromonitoring in anesthesia

Motor Evoked Potentials

Transcranial electrical MEP monitoring

Stimulating electrodes placed on scalp overlying motor cortex

Application of electrical current produces MEP

Stimulus propagated through descending motor pathways

Page 35: Neuromonitoring in anesthesia

Motor Evoked Potentials

MEPs very sensitive to anesthetic agents Possibly due to

anesthetic depression of anterior horn cells in spinal cord

Intravenous agents produce significantly less depression

TIVA often used

No muscle relaxant

Page 36: Neuromonitoring in anesthesia

EMG

Early detection of surgically induced nerve damage and assessment of level of nerve function intra-operatively.

Active or passive.

Uses:

1. Facial nerve monitoring

2. Trigeminal nerve monitoring

3. Spinal Accessory nerve

Page 37: Neuromonitoring in anesthesia
Page 38: Neuromonitoring in anesthesia

Cerebral blood flow and ICP monitoring

Page 39: Neuromonitoring in anesthesia

Intra-cranial Pressure

The pressure inside the lateral ventricles/lumbar subarachnoid space in supine position.

The normal value of ICP is 10-15 mm Hg in adults.

Page 40: Neuromonitoring in anesthesia

Indications for ICP monitoring

1. Head Injury

2. Brain Tumors

3. Subarachnoid Heamorrhage

4. Hydrocephalus

5. Neuromedical conditions

Page 41: Neuromonitoring in anesthesia

Techniques of ICP monitoring

Page 42: Neuromonitoring in anesthesia

ICP waveforms

ICP shows a pulsatile recording with slow respiratory component superimposed on a biphasic recording synchronous with cardiac cycle.

Normally, respiratory oscillations are greater than the cardiac oscillations, but when ICP increases, arterial pulsations also assume greater amplitude

Page 43: Neuromonitoring in anesthesia

Abnormalities of ICP waveforms

A WAVES: plateau waves indicate ICP above 40mmHg and are sustained for 5-20min.

B WAVES: Amplitude of 20mmHg and occur at the rate of 1-2/min. Occur synchronus with cheyne-stokes breathing

C WAVES: no pathological significance

Page 44: Neuromonitoring in anesthesia

Transcranial Doppler

Measures the blood flow velocity in major cerebral blood vessles.

Examination carried out through the temporal window, orbital foramen or foramen magnum.

Using 2MHz probe.

MCA commonly used.

Change in velocity is proportional to change in flow considering the vessel diameter is constant.

Page 45: Neuromonitoring in anesthesia

Interpretation of waveforms

Pulsatality Index = (Peak Systolic Velocity - EndDiastolic Velocity) / Mean Velocity

Page 46: Neuromonitoring in anesthesia

Clinical applications of TCD

1. It is useful as a noninvasive monitor of CBF.

2. It is helpful to diagnose cerebral vasospasm and monitor response to therapy in patients with subarachnoid haemorrhage and head injury.

3. It is used to study autoregulation of CBF and cerebral vascular response to carbon dioxide.

4. It can be used to assess intracranial circulatory status in raised ICP.

5. It can be a useful tool to identify intraoperative cerebral embolisation during surgery on carotid artery and cardiopulmonary bypass procedures.

6. It can be used to optimise CPP and hyperventilationin patients with head injury.

Page 47: Neuromonitoring in anesthesia

Intravascular tracer compounds

Method originally described by Kety and Schmidt.

Administration of radioactive isotope of xenon-133

Measurement of radioactivity washout with gamma detectors.

Disadvantages: 1.Exposure to radioactivity

2.Cumbersome detector equipment

3.Focal areas of hypoperfusion missed

4.Snapshot of CBF not continuous monitor.

Page 48: Neuromonitoring in anesthesia

Thermal diffusion cerebral blood flow monitoring

The rate at which heat dissipates in a tissue depends on the tissue’s thermal conductive properties and the blood flow in that area.

Measurement is automatically suspended if the passive thermistor measures a brain temperature of 39.1°C.

The inability to monitor during a febrile episode may constitute a true limitation of the technique

Page 49: Neuromonitoring in anesthesia

Monitoring of cerebral oxygenation and metabloism

Page 50: Neuromonitoring in anesthesia

Monitoring of cerebral oxygenation and metabloism

Brain tissue oxygenation

Jugular bulb venous oximetry monitoring

Microdialysis catheter

Near Infrared Spectroscopy (NIRS)

Page 51: Neuromonitoring in anesthesia

Jugular venous oximetry :principle

(A-V)DO2 x CBF = CMRO2

When CMRO2 is constant, any change in CBF is associated with a reciprocal change in the cerebral arteriovenous oxygen difference.

Based on the principle of reflectance oximetry.

Page 52: Neuromonitoring in anesthesia

Jugular venous oximetry

Continuous monitoring of jugular venous oxygen saturation (SjVO2 ) is carried out by a catheter placed retrograde through the internal jugular vein intothejugular bulb.

For accurate measurement, the tip of the catheter must be within 1 cm of the jugular bulb.

Page 53: Neuromonitoring in anesthesia

Indices obtained from SjVO2

1. Jugular venous oxygen saturation (SjVO2 )

2. Cerebral arteriovenousoxygen difference (A-VDO2 ) (the difference between arterial and jugularvenousoxygen content) and

3. Cerebral oxygen extraction(CEO2 ) (the difference between SaO2

and SjVO2 ).

Page 54: Neuromonitoring in anesthesia

Interpretation of SjVO2

Interpretation of jugular venous oxygen saturation (SjvO2) Increased values: >90% indicates absolute/relative

hyperemia Reduced metabolic need comatose/brain death

Excessive flove sever hypercapnia

AVM

Normal Values: 60-70% focal ischemia?

Decreased Values: <50% increased O2 extraction,indicates a potential risk of ischemia injury Increased demand: seizure / fever

Decreased supply: decreased flow, decreased hematocrit

As ischemiaprogress to infarction: O2 consumption decreases

Page 55: Neuromonitoring in anesthesia

Near Infra-red Spectroscopy NIRS

The principle of absorption of near-infrared light by chromophores in the body like oxyhaemoglobin,deoxyhaemoglobin and cytochrome aa3.

Light in the near-infrared region (70-1000 nm) is very minimally absorbed by body tissues. It can penetrate tissues upto 8 cm.

Measure regional cerebral blood flow, cerebral blood volume, cerebral oxygen saturation and cerebral metabolism.

Page 56: Neuromonitoring in anesthesia

NIRS limitations

Inability to assess the contribution of extracranial tissue to the signal changes.

Presence of intracranial blood in the form of haematomas and contusions can interfere with the measurements.

Measures small portion of frontal cortex, contributions from non-brain sources

Temperature changes affect NIR absorption water spectrum Degree of contamination of the signal by chromophores in

the skin can be appreciable and are variable Not validated – threshold for regional oxygen saturation not

known (20% reduction from baseline?)

Page 57: Neuromonitoring in anesthesia

Tissue partial pressure oxygen monitoring:

Based on an oxygen-sensitive electrode originally described by Clark.

The diffusion of oxygen molecules through an oxygen-permeable membrane into an electrolyte solution causes an electric current that is proportional to Po2.

The catheter is placed into the brain tissue through a twist drill hole into the subcortical white matter.

Normal values for brain tissue oxygen tension are 20-40 mmHg.

In patients with cerebral ischaemia the values are 10 ± 5 mmHg as against 37 ± 12 mmHg in normal individuals

Page 58: Neuromonitoring in anesthesia

Cerebral Microdialysis

Small catheter inserted with ICP/tissue PO2

monitor

Artificial cerebrospinal fluid,equilibrates with extracellular fluid,chemical composition analysis

Markers:

○ Lactate/pyruvate ratio : onset of ischemia

○ High level glycerol: inadequate energy to maintain cellular integrity- membrane breakdown

○ Glutamate: neuronal injury and a factor in its exacerbation

Page 59: Neuromonitoring in anesthesia

Catheter placement is usually in ‘high risk’ tissue.

Uses: 1.Ischemia/trauma

2.epilepsy

3.Tumor chemistry

Page 60: Neuromonitoring in anesthesia
Page 61: Neuromonitoring in anesthesia

References

Millers anesthesia 8th edition

Neurological monitoring. Dr. G S Rao IJA 2002;46(4)

Advances in neuroanesthesia monitoring Dr. Pramod Bithal AIIMS new delhi. 2006 ISACON

GE-Datex Ohmeda Entropy monitor manual

Coviden BIS monitor users manual

Page 62: Neuromonitoring in anesthesia

ThankyouThe end